Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024
October 30, 2024 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
October 11, 2024 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 04, 2024 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024
September 03, 2024 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Reports Second Quarter 2024 Financial Results
August 07, 2024 16:01 ET
|
Assertio Holdings, Inc.
Assertio Reports Second Quarter 2024 Financial Results
Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024
July 24, 2024 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
July 09, 2024 16:30 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., July 09, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 06, 2024 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., June 06, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024
June 05, 2024 08:30 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
May 29, 2024 07:00 ET
|
Assertio Holdings, Inc.
Assertio appoints Brendan P. O'Grady as CEO